Invasive pulmonale Aspergillose

Invasive pulmonary aspergillosis is a life-threatening disease occurring in patients with severe immunosuppression. It is classically associated with severe neutropenia following hematopoietic stem cell transplantation, but other risk factors include COPD, corticosteroid therapy, solid organ transplant, liver failure and preceding severe influenza infection. Due to the high mortality of the disease, rapid diagnosis and treatment are crucial. Diagnosis is based on CT scan and bronchoscopy including microscopy, culture and galactomannan detection in BAL. Histopathology remains the gold standard diagnosis but is not feasible in many cases. First line treatment is voriconazole, new recommendations also support the triazole isavuconazole.

[1]  H. Einsele,et al.  Invasive Fungal Infection. , 2019, Deutsches Arzteblatt international.

[2]  G. Behre,et al.  Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO) , 2018, Mycoses.

[3]  C. Beigelman-Aubry,et al.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  Felix Bongomin,et al.  Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision , 2017, Journal of fungi.

[5]  F. Maurer,et al.  Neue mikrobiologische Diagnostikverfahren , 2017, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[6]  J. Timsit,et al.  Intensive care medicine research agenda on invasive fungal infection in critically ill patients , 2017, Intensive Care Medicine.

[7]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Christner,et al.  Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study , 2016, Critical Care.

[9]  J. Baddley,et al.  Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial , 2016, The Lancet.

[10]  Johannes B Reitsma,et al.  Galactomannan detection for invasive aspergillosis in immunocompromised patients. , 2015, The Cochrane database of systematic reviews.

[11]  J. Rello,et al.  Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.

[12]  M. Antonelli,et al.  How to manage aspergillosis in non-neutropenic intensive care unit patients , 2014, Critical Care.

[13]  D. Denning,et al.  Burden of serious fungal infections in Germany , 2014 .

[14]  J. Rello,et al.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.

[15]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Denning,et al.  Laboratory diagnosis of invasive aspergillosis. , 2005, The Lancet. Infectious diseases.

[17]  J. Garnacho-Montero,et al.  Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome , 2005, Critical care.

[18]  A. Wilmer,et al.  Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.

[19]  H. Kauczor,et al.  Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.